Abstract
A catalytic conjunctive cross-coupling reaction is developed that allows the construction of chiral organoboronic esters from alkylboron ate complexes and alkyl iodide electrophiles. The process occurs most efficiently with a Ni/Pybox-comprised catalyst and with an acenapthoquinone-derived boron ligand. Because of the broad functional group tolerance of this reaction it can be a versatile tool for organic synthesis. Application to the construction of (R)-coniine and (−)-indolizidine 209D are described.
Graphical Abstract

Organoboronic acid derivatives are useful reagents in organic synthesis1, important structures in medicinal chemistry2 and chemical biology3, and have found applications in sensor technology and material science.4 One can prepare organoboron compounds with a variety of a different methods, however, there are gaps in synthetic methodology that hinder access to certain structural classes. This is especially the case if one wishes to use catalytic reactions to construct compounds with boron-containing stereogenic centers.5 For instance, while a number of reactions can produce secondary boronic esters in a catalytic enantioselective fashion, most of these transformations, as a consequence of their underpinning reaction mechanism, will lead to specialized products that contain sp2 carbons, directing groups, carbonyls, or other particular functional groups at defined locations. In so far as we are aware, the asymmetric catalytic Negishi coupling of α-chloroboronic esters (Scheme 1, eq. 1) developed by Fu is the only process able to furnish non-racemic secondary organoboronic esters containing simple alkyl substituents.6 In this manuscript, we present an alternate catalytic enantioselective route to non-functionalized organoboronic esters and show that a number of functional groups can be included at sites necessary to enable subsequent chemical synthesis.
Scheme 1.
Conjunctive Cross-Coupling with Alkenylboron ate complexes.
The conjunctive cross-coupling between organic electrophiles and alkenylboron ‘ate’ complexes (Scheme 1, eq. 2) is an efficient process that can furnish enantiomerically enriched organoboronic esters in a catalytic fashion.7,8 This reaction occurs by way of a 1,2-metalate shift wherein a substituent attached to the boron atom migrates to the α-carbon of the adjacent alkene with concomitant C-M bond formation occurring at Cβ (see inset Scheme 1).9 While initial studies employed palladium catalysts and C(sp2) electrophiles, the use of nickel complexes in conjunction with a pyridylbisoxazoline (pybox) ligand as the catalyst allowed for the use of C(sp3) electrophiles and promised to broaden the scope of this reaction, substantially.10 A critical limitation of the Ni/pybox-catalyzed process, however, was that aliphatic boron substituents were found to be recalcitrant migrating groups and there-fore the reaction was limited to construction of benzylic boronic esters. In this study, we examine the Ni/pybox-catalyzed coupling of C(sp3) electrophiles with alkyl(vinyl)boron-derived ate complexes (Scheme 1, eq. 3) and show that the boron ligand can be tuned to facilitate effective reaction.
Examination of the conjunctive coupling between a pinacolato alkylboron-derived ate complexes and (3-iodopropyl)benzene demonstrated the lack of reactivity with this class of boron reagent. Whereas the analogous phenyl-derived ate complex undergoes coupling in 70% yield (data not shown), as depicted in Table 1 (entry 1) when the migrating group is an n-butyl chain, the product obtained upon oxidation of 1, is formed in only 4% yield. Examination of the by-products in entry 1 showed that one competing side reaction is the alkylation of the pinacol ligand with the electrophile. To avoid this circumstance, we considered other boron ligand frameworks that might be either less basic or more sterically encumbered. As depicted in entry 2 and 3, replacement of pinacol with a neopentylglycolato group resulted in only 6% product yield, whereas use of acenapthoquinone-derived “mac”11 ligand led to a substantial improvement in reaction outcome: after oxidation of the boronic ester intermediate (2), the alcohol was isolated in 35% yield. Subsequent optimization led to further improvements: the use of increased catalyst loading (10% catalyst), the use of THF/DMSO mixture as the reaction solvent, and the use of [(TMEDA)Ni(o-tol)Cl] as the source of Ni ion resulted in a process that reproducibly delivered the conjunctive coupling product in about 65% yield and 99:1 enantiomer ratio when conducted at room temperature (entry 9).
Table 1.
Optimization of Ni-Catalyzed Conjunctive Coupling of a C(sp3) Electrophile with an Alkyl(vinyl)boronate Complex.a
![]() | ||||
|---|---|---|---|---|
| entry | (OR)2 | modifications | yield 3 (%) | er |
| 1 | pin | none | 4 | n/d |
| 2 | neo | none | 6 | n/d |
| 3 | mac | none | 35 | 99:1 |
| 4 | mac | 5% Ni(cod)2 | 16 | n/d |
| 5 | mac | 5% NiBr2·glyme | 11 | n/d |
| 6 | mac | 5% [methallyl)NiCl]2[Ni] 12% L1 |
41 | n/d |
| 7 | mac | 5% [methallyl)NiCl]2 12% L1, 3:1 THF/DMSO |
53 | 99:1 |
| 8 | mac | 10% [(TMEDA)Ni(o-tol)Cl] 12% L1, 3:1 THF:DMSO |
55 | 99:1 |
| 9 | mac | 10% [(TMEDA)Ni(o-tol)Cl] 12% L1, 3:1 THF:DMSO, r.t. |
65 | >99:1 |
![]() | ||||
Yield refers to isolated yield of purified product. er refers to the enantiomeric ratio and was determined by SFC chromatography on a chiral stationary phase.
With a workable catalytic system that allows the migration of aliphatic groups in conjunctive couplings with aliphatic electrophiles, we surveyed a number of other substrates. As depicted in Scheme 2, migrating chains that bear functional groups such as an alkene (4), ether (5), ketal (6), and carbamate (21) are accommodated in this reaction. In contrast to the Pd-catalyzed process that allows migrations of secondary and tertiary aliphatic groups,7a,b,f the Ni catalyzed process appears to be much more sensitive to steric effects: migration of an iso-propyl group from a B(mac)-derived ate complex occurred in only 32% yield. Of note, use of the pinacol derived ate complex could improve the yield of these more hindered substrates (18-20), however, the overall efficiency of these reactions still remains modest.
Scheme 2. Scope of Ni-Catalyzed Conjunctive Coupling with B(mac)-Derived Ate Complexes.a.
(a) Yield refers to isolated yield of purified product. er refers to the enantiomeric ratio and was determined by SFC chromatography on a chiral stationary phase. (b) Reaction employed the pinacol-derived boronate. (c) Reaction with the pinacol-derived boronate and at 45 °C.
In terms of the electrophile, the experiments in Scheme 2 suggest that the alkyl iodide component could have silyl (9) and alkyl ethers (10, 11), ketals (13), esters (14), and Boc-protected amines (15). It was also found that the alkyl iodide itself could contain a pinacol boronic ester and, in the case of 16, provides a route to a 1,6-diboronate. Lastly, while secondary iodides proved reactive (11), they gave lower yields than primary electrophiles (12% yield with cyclopentyl iodide, data not shown.
To assess the usefulness of the Ni(pybox)-catalyzed conjunctive coupling in preparative synthetic chemistry, we first examined the ability of this process to proceed effectively on larger scale. As depicted in Scheme 3, when 1.56 g of vi-nylB(mac) was treated with n-BuLi, followed by the catalyst and (3-iodopropropyl)benzene in THF/DMSO at room temperature for 22 h, the conjunctive coupling product 2 was isolated in 65% yield and with an enantioselectivity of 99.3:0.7 er. That the selectivity and efficiency for this process so closely mirror that observed on smaller scale bodes well for the general use of this reaction in chemical synthesis.
Scheme 3.
Gram-Scale Conjunctive Coupling.
To learn whether the conjunctive coupling might accommodate reactive functional groups that would be useful in the preparation of relevant alkaloid synthesis targets, we examined preparation of motifs that could participate in boronic ester amination or reductive amination. In the first scenario, the synthesis of enantiomerically-enriched Boc-protected coniine12 was addressed. To access this structure an alkyl iodide bearing an alkoxyamine was employed in the conjunctive coupling. In this case, product 22 (Scheme 4) was accessed in good yield and outstanding enantioselectivity. Subsequent removal of the Boc carbamate, followed by intramolecular amination13 of the organoboronic ester, and Boc protection (to facilitate isolation) delivered the product 24 in an efficient fashion.
Scheme 4.
Preparation of (R)-Coniine by Ni-Catalyzed Conjunctive Cross-Coupling.
As an alternate route to alkaloid natural products, we considered the reductive amination applied to substrates derived from conjunctive coupling. As shown in Scheme 5, (−)-indolizidine 209D14 was prepared by conducting the coupling with an electrophile bearing appropriately positioned ketal and benzyl ether functional groups. This reaction delivered compound 25 in good yield and >99:1 er. Subsequent amination of the boronic ester (to give 26), followed by ketal hydrolysis and imine reduction provided piperidine 27, which was then converted to the target 28 by a known route14c involving debenzylation and substitution at the primary carbon.
Scheme 5.
Preparation of (−)-Indolizidine 209D by Ni-Catalyzed Conjunctive Cross-Coupling.
In conclusion, the use of the “mac diol” ligand allows alkyl boronic ester-derived ate complexes to participate in highly selective conjunctive coupling reactions with aliphatic electrophiles. The reaction can be conducted on preparative scale and can accommodate a range of useful organic functional groups. We anticipate that these features will make this process useful to the synthetic chemist.
Supplementary Material
ACKNOWLEDGMENT
This work was supported by the NIH (R35-GM1217140).
Footnotes
The authors declare no competing financial interest.
ASSOCIATED CONTENT
Supporting Information.
Procedures, characterization and spectral data. This material is available free of charge via the Internet at http://pubs.acs.org.
The Supporting Information is available free of charge on the ACS Publications website.
REFERENCES
- (1).(a) Brown HC; Singaram B Acc. Chem. Res 1988, 21, 287. [Google Scholar]; (b) Matteson DS J. Org. Chem 2013, 78, 10009. [DOI] [PubMed] [Google Scholar]; (c) Leonori D; Aggarwal VK Angew. Chem. Int. Ed 2015, 54, 1082. [DOI] [PubMed] [Google Scholar]; (d) Sandford C; Aggarwal VK Chem. Commun 2017, 53, 5481. [DOI] [PubMed] [Google Scholar]; (e) Yang F; Zhu M; Zhang J; Zhou H Med. Chem. Commun 2018, 9, 201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (2).(a) Issa F; Kassiou M; Rendina LM Chem. Rev 2011, 111, 5701. [DOI] [PubMed] [Google Scholar]; (b) Diaz DB; Yudin AK Nature Chem. 2017, 9, 731. [DOI] [PubMed] [Google Scholar]; (c) Baker SJ; Tomsho JW; Benkovic SJ Chem. Soc. Rev 2011, 40, 4279. [DOI] [PubMed] [Google Scholar]; (d) Adamczyk-Wozniak A; Borys KM; Sporzynski A Chem. Rev 2014, 115, 5224. [DOI] [PubMed] [Google Scholar]
- (3).(a) Akgun B; Hall DG Angew. Chem. Int. Ed 2018, 57, 13028. [DOI] [PubMed] [Google Scholar]; (b) Cambray S; Gao J Acc. Chem. Res 2018, 51, 2198. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Bandyopadhyay A; Cambray S, Gao J J. Am. Chem. Soc 2017, 139, 871. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Bandyopadhyay A; Gao JJ Am. Chem. Soc 2016, 138, 2098. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Meadows MK; Roesner EK; Lynch VM; James TD; Anslyn EV Org. Lett 2017, 19, 3179. [DOI] [PubMed] [Google Scholar]; (f) Cal PMSD, Vicente JB; Pires E; Coelho AV; Veiros LF; Cordeiro C; Gois PMP J. Am. Chem. Soc 2012, 134, 10299. [DOI] [PubMed] [Google Scholar]; (g) Antonio JPM; Russo R; Carvalho CP; Cal PMSD; Gois PMP Chem. Soc. Rev 2019, 48, 3513. [DOI] [PubMed] [Google Scholar]
- (4).(a) Galbraitha E; James TD Chem. Soc. Rev 2010, 39, 3831. [DOI] [PubMed] [Google Scholar]; (b) Mellerup SK; Wang S Chem. Soc. Rev 2019, 48, 3537. [DOI] [PubMed] [Google Scholar]; (c) Wu X; Li Z; Chen X-X; Fossey JS; James TD; Jiang Y-B Chem. Soc. Rev 2013, 42, 8032. [DOI] [PubMed] [Google Scholar]; (d) Zhai W; Sun X; James TD; Fossey JS Chem. Asian J 2015, 10, 1836. [DOI] [PubMed] [Google Scholar]
- (5).Collins BSL; Wilson CM; Myers EL; Aggarwal VK Angew. Chem. Int. Ed 2017, 56, 11700. [DOI] [PubMed] [Google Scholar]
- (6).Schmidt J; Choi J; Liu AT; Slusarczyk M; Fu GC Science 2016, 354, 1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).(a) Zhang L; Lovinger GJ; Edelstein EK; Szymaniak AA; Chierchia MP; Morken JP Science 2016, 351, 70. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Lovinger GJ; Aparece MD; Morken JP J. Am. Chem. Soc 2017, 139, 3153. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Edelstein EK; Namirembe S; Morken JP J. Am. Chem. Soc 2017, 139, 5027. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Chierchia M; Law C; Morken JP Angew. Chem. Int. Ed 2017, 56, 11870; Angew. Chem. 2017, 129, 12032. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Lovinger GJ; Morken JP J. Am. Chem. Soc 2017, 139, 17293. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Myhill JA; Zhang L; Lovinger GJ; Morken JP Angew. Chem. Int. Ed 2018, 57, 12799; Angew. Chem. 2018, 130, 12981. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Myhill JA; Wilhelmsen CA; Zhang L; Morken JP; J. Am. Chem. Soc 2018, 140, 15181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).For aligned processes, see:; (a) Law C; Meng Y; Koo SM; Morken JP Angew. Chem. Int. Ed 2019, 58, 6654; Angew. Chem. 2019, 131, 6726. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Liu Z; Li X; Zeng T; Engle KM ACS Catal. 2019, 9, 3260. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Derosa J; Tran VT; Boulous MN; Chen JS; Engle KM J. Am. Chem. Soc 2017, 139, 10657. [DOI] [PubMed] [Google Scholar]; (d) Derosa J; Kleinmans R; Tran VT; Karunananda MK; Wisniewski SR; Eastgate MD; Engle KM J. Am. Chem. Soc 2018, 140, 17878. [DOI] [PubMed] [Google Scholar]; (e) Derosa J; van der Puyl VA; Tran VT; Liu M; Engle KM Chem. Sci 2018, 9, 5278. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Kischkewitz M; Okamoto K; Mgck-Lichtenfeld C; Studer A Science 2017, 355, 936. [DOI] [PubMed] [Google Scholar]; (g) Cheng Y; Mück-Lichtenfeld C; Studer AJ Am. Chem. Soc 2018, 140, 6221. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Silvi M; Sandford C; Aggarwal VK J. Am. Chem. Soc 2017, 139, 5736. [DOI] [PubMed] [Google Scholar]
- (9).Namirembe S; Morken JP Chem. Soc. Rev 2019, 48, 3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Lovinger GJ; Morken JP J. Am. Chem. Soc 2017, 139, 17293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Prepared in one step from acenaphthoquinone. For details, see reference 7g
- (12).Isolation:; (a) Hotti H; Rischer H Molecules 2017, 22, 1962 Recent syntheses: [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Reding MT; Buchwald SL J. Org. Chem 1998, 63, 6344. [DOI] [PubMed] [Google Scholar]; (c) Friestad GK; Marie J-C; Suh Y; Qin J J. Org. Chem 2006, 71, 7016. [DOI] [PubMed] [Google Scholar]; (d) Daly M; Gill K; Sime M; Simpson GL; Sutherland A Org. Biomol. Chem 2011, 9, 6761. [DOI] [PubMed] [Google Scholar]
- (13).For the intermolecular version of this process, see:; (a) Mlynarski SN; Karns AS; Morken JP J. Am. Chem. Soc 2012, 134, 16449. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Edelstein EK; Grote AC; Palkowitz MD; Morken JP Synlett 2018, 29, 1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Isolation:; (a) Daly JW; Spande TF; Garraffo HM J. Nat. Prod 2005, 68, 1556 Recent syntheses: [DOI] [PubMed] [Google Scholar]; (b) Kim G; Shim JH; Kim JH Bull. Korean Chem. Soc 2003, 24, 1832. [Google Scholar]; (c) Coia N; Mokhtari N; Vasse J-L; and Szymoniak J Org. Lett 2011, 13, 6292. [DOI] [PubMed] [Google Scholar]; (d) Chiou W-H; Chen H-Y RSC Adv. 2017, 7, 684. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







